Circulating Tumor Cells: A New Aid for Cancer Diagnosis

Press Release   •   Sep 11, 2014 15:38 IST

Circulating tumor cells (CTCs) are malignant cells that originate from primary or metastatic tumors and are found in the peripheral blood. Recently, it has been demonstrated that these CTCs reflect molecular features of cells within the tumor masses, providing live information about the patient’s disease status. Market players are investing millions of dollars in R&D to research new devices for capturing CTCs. In a recent development, Fluxion Biosciences introduced an instrument to isolate rare CTCs. Using their proprietary microfluidic technology, the IsoFlux system processes CTCs, which are optimized for downstream molecular testing, such as real-time PCR, next-generation sequencing, and immunoassays.

Our study, “Global In-Vitro Diagnostics Market Forecast to 2018”, elaborates on more such trends. The report discusses each region’s current and future outlook for 2018. Further, each market has been broken down into eight distinct clinical segmentations, and their current and future outlook for 2018 has been analyzed to provide a thorough opportunity assessment.

Besides, the report has delved into the business dynamics of the major players of the market. To provide a thorough understanding of the company’s business model, the company’s current and historical Financials have been analyzed. Moreover, each company’s strengths and weaknesses along with their recent industrial activities have also been assessed. This will help the reader to gain a deeper insight into the current competitive landscape and position its company accordingly.

The report provides a thorough research and rational analysis of the current status and expected position of the global IVD market. The analysis of the emerging sectors and key players in the market provides a holistic view to the reader. Explaining some of the constraints faced by the industry, the study also covers the emerging trends which would have a positive impact on the market growth. Overall, the report contains key actionable insights that will help the reader to gain a deeper knowledge of the industry, identify opportunities and design suitable business strategies.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM679.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm


RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.